Hydrochloric Acid → HCID 178468189, compound

HRID 1751701Notes

Reaction equation

HRID 1751701 reaction equation
[CH2:1]([O:3][C@@H:4]1[CH2:8][N:7]([C:9](=[O:19])[C@H:10]([CH:16]([CH3:18])[CH3:17])[NH:11][C:12]([O:14][CH3:15])=[O:13])[C@H:6]([C:20]2[NH:24][C:23]3[C:25]4[C:30]([CH:31]=[CH:32][C:22]=3[N:21]=2)=[CH:29][C:28]2[C:33]3[C:38]([CH2:39][O:40][C:27]=2[CH:26]=4)=[CH:37][C:36]([C:41]2[NH:45][C:44]([C@@H:46]4[CH2:50][CH2:49][CH2:48][N:47]4C(OC(C)(C)C)=O)=[N:43][CH:42]=2)=[CH:35][CH:34]=3)[CH2:5]1)[CH3:2].Cl.[CH3:59][O:60][C:61]([NH:63][C@@H:64]([CH:68]([CH3:70])[CH3:69])[C:65](O)=[O:66])=[O:62].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C>C(Cl)Cl.CO.CN(C=O)C.[Li+].[OH-]>[CH2:1]([O:3][C@@H:4]1[CH2:8][N:7]([C:9](=[O:19])[C@@H:10]([NH:11][C:12]([O:14][CH3:15])=[O:13])[CH:16]([CH3:18])[CH3:17])[C@H:6]([C:20]2[NH:24][C:23]3[C:25]4[C:30]([CH:31]=[CH:32][C:22]=3[N:21]=2)=[CH:29][C:28]2[C:33]3[C:38]([CH2:39][O:40][C:27]=2[CH:26]=4)=[CH:37][C:36]([C:41]2[NH:45][C:44]([C@@H:46]4[CH2:50][CH2:49][CH2:48][N:47]4[C:65](=[O:66])[C@@H:64]([NH:63][C:61](=[O:62])[O:60][CH3:59])[CH:68]([CH3:70])[CH3:69])=[N:43][CH:42]=2)=[CH:35][CH:34]=3)[CH2:5]1)[CH3:2]

Participants

10

Procedure

To a solution of tert-butyl (2S)-2-[5-(2-{(2S,4S)-4-ethoxy-1-[N-(methoxycarbonyl)-L-valyl]pyrrolidin-2-yl}-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate (0.048 g, 0.062 mmol) in a mixture of CH2Cl2 (1.0 mL) and MeOH (0.25 mL) was added HCl (in dioxanes, 4M, 0.47 mL, 1.9 mmol). The solution was stirred at room temperature for 3 h, and then concentrated to dryness under reduced pressure. To the crude intermediate suspended in CH2Cl2 (1.5 mL) was added (S)-2-(methoxycarbonylamino)-3-methylbutanoic acid (0.012 g, 0.069 mmol), HATU (0.029 g, 0.076 mmol), and DIPEA (0.050 mL, 0.28 mmol). The resulting solution was stirred at room temperature for 1.5 h. The reaction was diluted with DMF and aqueous LiOH (2.5 M, 4 drops) was added. The solution was concentrated to remove the CH2Cl2 and the crude residue was purified by preparative reverse phase HPLC (10% to 52% MeCN/water with 0.1% TFA). The desired fractions were combined and concentrated under reduced pressure to remove volatile organics. The addition of aqueous sodium bicarbonate with stirring resulted in precipitation of a white solid. The precipitate was filtered through a membrane filter and washed with water. Drying under reduced pressure afforded methyl {(2S)-1-[(2S)-2-(5-{2-[(2S,4S)-4-ethoxy-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl}-1H-imidazol-2-yl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate (0.008 g, 17%). 1H-NMR: 400 MHz, (MeOD) δ: (Mixture of rotomers) 8.37 (s, 1H), 7.97 (s, 2H), 7.37-7.76 (m, 5H), 5.38-5.54 (m, 1H), 5.18 (s, 2H), 5.14-5.16 (m, 1H), 4.21-4.31 (m, 4H), 3.87-4.09 (m, 1H), 3.79-3.85 (m, 2H), 3.66 (s, 3H), 3.64 (s, 3H), 3.46-3.55 (m, 2H), 2.30-2.35 (m, 3H), 2.04-2.06 (m, 3H), 1.11 (m, 2H), 0.95 (d, 3H), 0.88 (d, 3H). MS (ESI) m/z 836.02 [M+H]+.

Workup

  1. concentrationconcentrated to dryness under reduced pressure
  2. stirringThe resulting solution was stirred at room temperature for 1.5 h
  3. additionwas added
  4. concentrationThe solution was concentrated
  5. customto remove the CH2Cl2
  6. customthe crude residue was purified by preparative reverse phase HPLC (10% to 52% MeCN/water with 0.1% TFA)
  7. concentrationconcentrated under reduced pressure
  8. customto remove volatile organics
  9. additionThe addition of aqueous sodium bicarbonate
  10. stirringwith stirring
  11. customresulted in precipitation of a white solid
  12. filtrationThe precipitate was filtered through a membrane
  13. filtrationfilter
  14. washwashed with water
  15. customDrying under reduced pressure

Sources & evidence

ORD record
ord-05bb910fa735434aa176768dfbe78970
Source dataset
uspto-grants-2015_10
Patent number
US09156823B2

Reaction notes

Loading…